Literature DB >> 14641647

Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy.

Paul Fernyhough1, Tze-Jen Huang, Alex Verkhratsky.   

Abstract

Symmetrical sensory polyneuropathy, the most common form of diabetic neuropathy in humans, is associated with a spectrum of structural changes in peripheral nerve that includes axonal degeneration, paranodal demyelination, and loss of myelinated fibers--the latter probably the result of a dying-back of distal axons. Mitochondrial dysfunction has recently been proposed as an etiological factor in this degenerative disease of the peripheral nervous system. Lack of neurotrophic support has been proposed as a contributing factor in the etiology of diabetic neuropathy based on studies in animal models of Type I diabetes. We have recently demonstrated that insulin and neurotrophin-3 (NT-3) modulate mitochondrial membrane potential in cultured adult sensory neurons. We therefore tested the hypothesis that diabetes-induced mitochondrial dysfunction is caused by impairments in neurotrophic support. We have used real-time fluorescence video microscopy to analyze mitochondrial membrane potential in cultured adult sensory neurons isolated from normal and diabetic rats. Diabetes caused a significant loss of mitochondrial membrane potential in all sub-populations of sensory neurons which can be prevented by in vivo treatment with insulin or NT-3. The mechanism of insulin and NT-3-dependent modulation of mitochondrial membrane potential involves the activation of the phosphoinositide 3 kinase (PI 3 kinase) pathway. Downstream targets of PI 3 kinase, such as Akt and the transcription factor cAMP response element-binding protein (CREB), are activated by insulin and NT-3 and regulate sensory neuron gene expression. These alterations in gene expression modulate critical components of metabolite pathways and the electron transport chain associated with the neuronal mitochondrion. Our results show that in adult sensory neurons, treatment with insulin can elevate the input of reducing equivalents into the mitochondrial electron transport chain, which leads to greater mitochondrial membrane polarization and enhanced ATP synthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641647     DOI: 10.1111/j.1085-9489.2003.03028.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  28 in total

1.  Dorsal Root Ganglia Mitochondrial Biochemical Changes in Non-diabetic and Streptozotocin-Induced Diabetic Mice Fed with a Standard or High-Fat Diet.

Authors:  B L Guilford; J M Ryals; E Lezi; R H Swerdlow; D E Wright
Journal:  J Neurol Neurosci       Date:  2017-03-27

2.  Effect of photobiomodulation on mitochondrial dynamics in peripheral nervous system in streptozotocin-induced type 1 diabetes in rats.

Authors:  Igor Rafael Correia Rocha; Edward Perez-Reyes; Marucia Chacur
Journal:  Photochem Photobiol Sci       Date:  2021-02-18       Impact factor: 3.982

3.  Inhibition of macrophage oxidative stress prevents the reduction of ABCA-1 transporter induced by advanced glycated albumin.

Authors:  Raphael de Souza Pinto; Gabriela Castilho; Bruno Alves Paim; Adriana Machado-Lima; Natalia M Inada; Edna Regina Nakandakare; Aníbal Eugênio Vercesi; Marisa Passarelli
Journal:  Lipids       Date:  2012-01-21       Impact factor: 1.880

4.  Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function.

Authors:  Andreu Viader; Judith P Golden; Robert H Baloh; Robert E Schmidt; Daniel A Hunter; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

5.  Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.

Authors:  Liang Zhang; Cuijuan Yu; Francisco E Vasquez; Nadya Galeva; Isaac Onyango; Russell H Swerdlow; Rick T Dobrowsky
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

6.  Cellular Senescence: A New Player in Kidney Injury.

Authors:  Yongxin Li; Lilach O Lerman
Journal:  Hypertension       Date:  2020-08-31       Impact factor: 10.190

7.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

8.  Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.

Authors:  Asieh Hosseini; Mohammad Sharifzadeh; Seyed Mahdi Rezayat; Gholamreza Hassanzadeh; Shokoufeh Hassani; Maryam Baeeri; Vahid Shetab-Bushehri; Dmitry A Kuznetsov; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2010-08-09

9.  Intranasal insulin ameliorates experimental diabetic neuropathy.

Authors:  George Francis; Jose Martinez; Wei Liu; Thuhien Nguyen; Amit Ayer; Jared Fine; Douglas Zochodne; Leah R Hanson; William H Frey; Cory Toth
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

10.  Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.

Authors:  Elizabeth J Pawson; Beatriz Duran-Jimenez; Richard Surosky; Heather E Brooke; S Kaye Spratt; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.